Stories

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

We leave the lab to find out what people know about cell and gene therapy.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers are working to extend the life of organ transplants

How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.

Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

Learn how Novartis researchers are working to outsmart tumors.